Yüklüyor......

First-Line Chemotherapy With Capecitabine and Temozolomide in Patients With Metastatic Pancreatic Endocrine Carcinomas

BACKGROUND: Temozolomide is an active agent in metastatic pancreatic endocrine carcinomas. In vitro data indicate that the combination of capecitabine and temozolomide is synergistic for induction of apoptosis in neuroendocrine tumor cell lines. The authors retrospectively evaluated the efficacy of...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer
Asıl Yazarlar: Strosberg, Jonathan R., Fine, Robert L., Choi, Junsung, Nasir, Aejaz, Coppola, Domenico, Chen, Dung-Tsa, Helm, James, Kvols, Larry
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2010
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4665634/
https://ncbi.nlm.nih.gov/pubmed/20824724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.25425
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!